Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
J Hazardous Materials Advances
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
Fades Dark Spots & Acne Marks By controlling melanin production and repairing damaged cells, Glutathione helps fade: Dark spots Sun spots Pigmentation Melasma Acne scars 3
Conversion ratio of tryptophan to niacin in Japanese women fed a purified diet conforming to the Japanese Dietary Reference Intakes
Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake
Elham et al
US$ 28.32
US$ 21.67
US$ 21.73
US$ 26.88
US$ 28.19
US$ 28.45
US$ 20.47
US$ 23.60